Annexon has completed enrollment in its phase 3 ARCHER II trial of vonaprument (formerly ANX007) for dry age-related macular ...

The average uncorrected visual acuity changed from 0.79 ± 0.42 logMAR at baseline to 0.76 ± 0.49 logMAR at year 1 and 0.86 ± 0.46 logMAR at 10 years, with uncorrected visual acuity worsening by ...

A novel, at-home test was accurate and reliable in measuring near visual acuity and may be a helpful self-monitoring tool for patients with chronic ocular conditions or limited access to ...

Visual acuity improved significantly over a 6-month period when patients received intravitreal ranibizumab injections (IRI), according to a study published in the Journal of Clinical Medicine. 1 ...

Poor visual acuity, defined as difficulty discerning letters or numbers at a given distance, is associated with depression in middle-aged and older individuals, new research suggests.. After ...